Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$114.17 - $185.35 $4.77 Million - $7.74 Million
41,775 Added 75.83%
96,862 $17.4 Million
Q3 2023

Nov 09, 2023

BUY
$138.78 - $176.51 $7.64 Million - $9.72 Million
55,087 New
55,087 $8.76 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.22B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Wafra Inc. Portfolio

Follow Wafra Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wafra Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wafra Inc. with notifications on news.